The rights issue of Brooks Laboratories opens for subscription on Wednesday. It plans to issue up to 76.66 lakh equity shares of face value ₹10 each for cash at a price of ₹20 a share for an amount aggregating up to ₹15.33 crore on rights basis.
The rights entitlement ratio has been fixed at nine rights equity shares for every 20 fully paid-up equity shares held by the equity shareholders on the record date, i.e. February 12. Shareholders and investors would watch the response to the rights issue.